Xiaojiang Cui

8.5k total citations
121 papers, 6.1k citations indexed

About

Xiaojiang Cui is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaojiang Cui has authored 121 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 62 papers in Oncology and 35 papers in Cancer Research. Recurrent topics in Xiaojiang Cui's work include Cancer Cells and Metastasis (32 papers), HER2/EGFR in Cancer Research (18 papers) and Breast Cancer Treatment Studies (11 papers). Xiaojiang Cui is often cited by papers focused on Cancer Cells and Metastasis (32 papers), HER2/EGFR in Cancer Research (18 papers) and Breast Cancer Treatment Studies (11 papers). Xiaojiang Cui collaborates with scholars based in United States, China and Japan. Xiaojiang Cui's co-authors include Adrian V. Lee, Armando E. Giuliano, Ying Qu, Bingchen Han, Rachel Schiff, Steffi Oesterreich, Grazia Arpino, C. Kent Osborne, Yukun Cui and Manran Liu and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Xiaojiang Cui

116 papers receiving 6.0k citations

Peers

Countries citing papers authored by Xiaojiang Cui

Since Specialization

Citations

This map shows the geographic impact of Xiaojiang Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojiang Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojiang Cui more than expected).

Fields of papers citing papers by Xiaojiang Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojiang Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojiang Cui. The network helps show where Xiaojiang Cui may publish in the future.

Co-authorship network of co-authors of Xiaojiang Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojiang Cui. A scholar is included among the top collaborators of Xiaojiang Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojiang Cui. Xiaojiang Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted Treatment of Sarcomas by Single Protein Encapsulated Doxorubicin with Undetectable Cardiotoxicity and Superior Efficacy 2025 ·Cancers ·Changjun Yu, Faqing Huang, (unknown), Mengmeng Liu, Warren Chow, Xiang Ling, Fengzhi Li, Galen Cook‐Wiens, Linrong Li, Xiaojiang Cui	0
2	AI‐Driven De Novo Design of Ultra Long‐Acting GLP‐1 Receptor Agonists 2025 ·Advanced Science ·(unknown), (unknown), Xiaojiang Cui, Jiahui Lin, (unknown), Cheng Liu, (unknown), Xiao Lin, Junjie Zhu, (unknown), (unknown), Luke Johnston, Zhangsheng Yu, Haifeng Chen	0
3	PCBP2 Mediates Olaparib Resistance in Breast Cancer by Inhibiting m6A Methylation to Stabilize PARP1 mRNA 2025 ·Cancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Armando E. Giuliano, Xiaojiang Cui, (unknown), Jundong Wu, Stanley L. Lin, (unknown)	0
4	Tryptophan 2,3‐dioxygenase‐positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine‐mediated ferroptosis resistance of metastatic cells and T cell dysfunction 2024 ·Cancer Communications ·(unknown), (unknown), Xueying Wan, Rui Wang, Haojun Luo, Chao Chang, (unknown), (unknown), (unknown), Yixuan Hou, (unknown), Yong Teng, Xiaojiang Cui, Manran Liu	16
5	Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy 2023 ·Stem Cell Reports ·(unknown), Bowen Gao, (unknown), (unknown), (unknown), Qizhi Liu, Faqing Huang, Changjun Yu, Yi Zhang, Xuemo Fan, Amelia Jenkins, Armando E. Giuliano, Paul W. Burridge, Xiaojiang Cui, Arun Sharma	11
6	FOXC1 restrains NF‐κB‐mediated interleukin‐1β transcription in breast cancer 2023 ·SHILAP Revista de lepidopterología ·Yan Liu, Shuang Chen, Mao Tian, Armando E. Giuliano, Xiaojiang Cui	1
7	Single protein encapsulated SN38 for tumor-targeting treatment 2023 ·Journal of Translational Medicine ·Changjun Yu, Faqing Huang, (unknown), Mengmeng Liu, Warren Chow, Xiang Ling, Fengzhi Li, Jason Causey, Xiuzhen Huang, Galen Cook‐Wiens, Xiaojiang Cui	4
8	miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC 2022 ·Cancers ·Tomohiro Shibata, Duo‐Yao Cao, (unknown), Faizan Ahmed, Shabir Ahmad Bhat, Luciana C. Veiras, Ellen A. Bernstein, Abdul Arif Khan, (unknown), Stephen L. Shiao, Warren G. Tourtellotte, Jorge F. Giani, Kenneth E. Bernstein, Xiaojiang Cui, Eric Vail, Zakir Khan	8
9	Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer 2017 ·PLoS ONE ·(unknown), Hiromasa Yamamoto, Hirotaka Kanzaki, Ken Suzawa, Takahiro Yoshioka, Shuta Tomida, Xiaojiang Cui, Ramachandran Murali, Kei Namba, Hiroki Sato, Hidejiro Torigoe, Mototsugu Watanabe, Kazuhiko Shien, Junichi Soh, Hiroaki Asano, Kazunori Tsukuda, Yoshihisa Kitamura, Shinichiro Miyoshi, Toshiaki Sendo, Shinichi Toyooka	29
10	Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer 2016 ·Cell Communication and Signaling ·Susan M. Farabaugh, (unknown), Xiaojiang Cui, Robert K. Dearth, Adrian V. Lee	7
11	Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay 2015 ·JNCI Journal of the National Cancer Institute ·Tor Jensen, Tania Ray, Jinhua Wang, Xiaodong Li, Wesley Y. Naritoku, Bingchen Han, Frank J. Bellafiore, Sanjay P. Bagaria, Annie Qu, Xiaojiang Cui, Clive R. Taylor, Partha S. Ray	46
12	Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer 2015 ·Clinical Breast Cancer ·Alice Chung, Michael Choi, (unknown), Shikha Bose, Xiao Zhang, Lali K. Medina‐Kauwe, Jessica Sims, Ramachandran Murali, (unknown), (unknown), Rachel Schiff, Armando E. Giuliano, Xiaojiang Cui	9
13	Current Status of Anti–Human Epidermal Growth Factor Receptor 2 Therapies: Predicting and Overcoming Herceptin Resistance 2013 ·Clinical Breast Cancer ·Alice Chung, Xiaojiang Cui, William Audeh, Armando E. Giuliano	57
14	Sustained c-Jun-NH2-Kinase Activity Promotes Epithelial-Mesenchymal Transition, Invasion, and Survival of Breast Cancer Cells by Regulating Extracellular Signal-Regulated Kinase Activation 2010 ·Molecular Cancer Research ·Jinhua Wang, Isere Kuiatse, Adrian V. Lee, Jingxuan Pan, Armando E. Giuliano, Xiaojiang Cui	70
15	FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer 2010 ·Cancer Research ·Partha Ray, Jinhua Wang, Ying Qu, Myung‐Shin Sim, Jaime Shamonki, Sanjay P. Bagaria, Xing Ye, Bingya Liu, David Elashoff, Dave S.�B. Hoon, Michael A. Walter, John W.M. Martens, Andrea L. Richardson, Armando E. Giuliano, Xiaojiang Cui	199
16	Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail 2007 ·Molecular and Cellular Biology ·Hyun Jung Kim, Beate C. Litzenburger, Xiaojiang Cui, David A. Delgado, Brian C. Grabiner, Xin Lin, Michael T. Lewis, Marco M. Gottardis, Tai W. Wong, Ricardo M. Attar, Joan M. Carboni, Adrian V. Lee	196
17	Epidermal Growth Factor Induces Insulin Receptor Substrate-2 in Breast Cancer Cells via c-Jun NH2-Terminal Kinase/Activator Protein-1 Signaling to Regulate Cell Migration 2006 ·Cancer Research ·Xiaojiang Cui, Hyun Jung Kim, Isere Kuiatse, Heetae Kim, Powel H. Brown, Adrian V. Lee	62
18	Progesterone Receptor Loss Correlates with Human Epidermal Growth Factor Receptor 2 Overexpression in Estrogen Receptor–Positive Breast Cancer 2006 ·Clinical Cancer Research ·Hyun‐Jung Kim, Xiaojiang Cui, Susan G. Hilsenbeck, Adrian V. Lee	49
19	Resistance to Mixed PVY and PLRV Infection in Potato Cultivars Expressing Dual PVY and PLRV Coat Protein Genes 1997 ·Journal of Integrative Plant Biology ·(unknown), (unknown), (unknown), Tianran Li, Meng Qing, Cong Li, Xiaojiang Cui	2
20	Construction of Plant Expression Vectors and Identification of Transgenic Potato Plants 1994 ·Journal of Integrative Plant Biology ·(unknown), Cong Li, Linlin Hou, Lizhi Zhang, (unknown), (unknown), Xiaojiang Cui, Xue‐Rong Zhou, (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact